Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-24-101877
Filing Date
2024-08-29
Accepted
2024-08-29 16:16:54
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 evoke_s-3_and_atm_prospe.htm S-3 699210
2 EX-4.9 evok-ex4_9.htm EX-4.9 502510
3 EX-5.1 evok-ex5_1.htm EX-5.1 48161
4 EX-5.2 evok-ex5_2.htm EX-5.2 30745
5 EX-23.1 evok-ex23_1.htm EX-23.1 4009
6 EX-FILING FEES evok-exfiling_fees.htm EX-FILING FEES 64991
7 GRAPHIC img78737429_0.jpg GRAPHIC 19587
8 GRAPHIC img78737429_1.jpg GRAPHIC 19587
9 GRAPHIC img78737429_2.jpg GRAPHIC 19587
10 GRAPHIC img143151495_0.jpg GRAPHIC 58631
11 GRAPHIC img144075016_0.jpg GRAPHIC 58631
  Complete submission text file 0000950170-24-101877.txt   1593690
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281840 | Film No.: 241263927
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)